Joseph Stringer

Stock Analyst at Needham

(0.78)
# 2071
Out of 5,321 analysts
329
Total ratings
32.81%
Success rate
-5.79%
Average return
23 Stocks
Name Action Price Target Current % Upside Ratings Updated
PHAT Phathom Pharmaceutic...
Reiterates: Buy
28 28
4.08 586.27% 51 Apr 21, 2025
IONS Ionis Pharmaceutical...
Reiterates: Buy
60 60
29.41 104.01% 20 Apr 15, 2025
CDTX Cidara Therapeutics
Reiterates: Buy
35 35
21.01 66.59% 10 Apr 10, 2025
RNA Avidity Biosciences
Reiterates: Buy
60 60
30.16 98.94% 17 Apr 9, 2025
STOK Stoke Therapeutics
Reiterates: Buy
22 22
9.58 129.65% 22 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
320 320
242.59 31.91% 21 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
90 90
33.18 171.25% 17 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15 15
0.97 1446.39% 18 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
66 66
62.27 5.99% 23 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 13 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
16 16
1.81 783.98% 18 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
10 10
n/a n/a 17 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
6.08 212.5% 16 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 4 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 5 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 8 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
85 60
17.57 241.49% 19 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 16 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
37
14.66 152.39% 5 Jan 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 5 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 32
n/a n/a 1 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 18
9.36 92.31% 2 Aug 24, 2021